Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Sell

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Iridex Corp (IRIX)

Electromedical & Electrotherapeutic Apparatus

https://www.iridex.com

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

1212 TERRA BELLA AVE
MOUNTAIN VIEW, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/16/1996

Market Cap

30,819,748

Shares Outstanding

16,250,000

Weighted SO

16,247,813

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

AZYO --.--%

AIMD --.--%

SRDX --.--%

LNSR --.--%

AMEUF --.--%

AIMDW --.--%

ARMM --.--%

CLLKF --.--%

BBLGW --.--%

Beta

0.8390

Last Div

0.0000

Range

1.32-3.65

Chg

-0.0232

Avg Vol

27806

Mkt Cap

30819748

Exch

NASDAQ

Country

US

Phone

650 940 4700

DCF Diff

1.2873

DCF

3.5373

Div Yield

0.0000

P/S

0.6201

EV Multiple

-3.1685

P/FV

7.1608

Div Yield %

0.0000

P/E

-2.8005

PEG

-0.3904

Payout

0.0000

Current Ratio

1.5489

Quick Ratio

0.8599

Cash Ratio

0.2546

DSO

59.0610

DIO

136.0221

Op Cycle

195.0831

DPO

94.9734

CCC

100.1097

Gross Margin

0.3994

Op Margin

-0.2153

Pretax Margin

-0.2159

Net Margin

-0.2185

Eff Tax Rate

-0.0116

ROA

-0.3474

ROE

-1.3437

ROCE

-0.7084

NI/EBT

1.0116

EBT/EBIT

1.0030

EBIT/Rev

-0.2153

Debt Ratio

0.0733

D/E

0.5391

LT Debt/Cap

0.2336

Total Debt/Cap

0.3503

Int Coverage

0.0000

CF/Debt

-2.5055

Equity Multi

7.3596

Rec Turnover

6.1801

Pay Turnover

3.8432

Inv Turnover

2.6834

FA Turnover

20.8736

Asset Turnover

1.5905

OCF/Share

-0.3521

FCF/Share

-0.3554

Cash/Share

0.2524

OCF/Sales

-0.1154

FCF/OCF

1.0092

CF Coverage

-2.5055

ST Coverage

-5.7638

CapEx Coverage

-108.2075

Div&CapEx Cov

-108.2075

P/BV

7.1608

P/B

7.1608

P/S

0.6201

P/E

-2.8005

P/FCF

-5.3248

P/OCF

-5.3016

P/CF

-5.3016

PEG

-0.3904

P/S

0.6201

EV Multiple

-3.1685

P/FV

7.1608

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 17, 01:15 Medical Lasers Market Size is Projected to Reach USD 12.02 billion by 2033, Growing at a CAGR of 9.10%: Straits Research GlobeNewswire Inc. Jan 11, 18:45 Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma GlobeNewswire Inc. Jan 11, 18:45 Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma GlobeNewswire Inc. Jan 11, 18:45 Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma GlobeNewswire Inc. Jan 11, 18:45 Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma GlobeNewswire Inc. Jan 11, 18:45 Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma GlobeNewswire Inc. Jan 11, 18:45 Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma GlobeNewswire Inc. Jan 11, 18:45 Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma GlobeNewswire Inc. Jan 11, 18:45 Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma GlobeNewswire Inc. Dec 28, 18:00 Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation GlobeNewswire Inc. Nov 27, 09:00 Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation

Revenue Product Segmentation